Medifast Q2 revenue falls 37.4% to $105.6M; active coaches down 33%; Q3 guidance weak

MEDIFAST INC

2025-Q2 EPS reported $0.15 revenue$221,283,000

Revenue $105.6M, down 37.4% YoY; active OPTA VIA coaches 22,800 (-32.7% YoY); diluted EPS $0.22 (includes $2.0M net LifeMD gain).
Net income $2.5M vs. loss $8.2M a year ago; operating loss improved to $1.1M from $7.9M.
Cash and investments $162.7M, no debt; LifeMD stake sold during quarter.
Q3 2025 guidance: revenue $70M-$90M; diluted EPS range ($0.60) to $0.00.
Management cites ongoing client acquisition challenges and GLP-1 competition.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.